HUGEN's RYAN MINSTER talks about how his interest in body composition and obesity led him to Samoa. "Polynesians and Micronesians have some of the highest rates of overweight and obesity in the world." He and his lab explored genetic factors that could be leading to increases in weight in a sample of Samoans.
TRIB LIVE – LifeX will tackle some of medicine’s biggest challenges for its initial focus. They announced a $2 million grant from the Henry L. Hillman Foundation to help it get off the ground. “The LifeX team is proud to have the Hillman Foundation's support as we continue this longstanding legacy of facilitating cures to the most devastating and prevalent causes of suffering and death”, says CEO of LifeX and HUGEN’s DIETRICH STEPHAN.
PITTWIRE - Doctoral alumna MALIHA ZAHID ( HUGEN '09) aims to reduce the amount of radiation that patients are exposed to when undergoing diagnostic imaging. Her creation, to be used during cardiac stress tests, was a previous Pitt PInCh winner.
UCSF NEWS - A study that involved combing through more than 50 years of data to assess the link between asthma and daycare and preschool attendance may provide welcome reassurance to working parents. Early child care does not boost children’s risk for developing this common respiratory disease, according to the study led by researchers including JUAN CELEDON, EPI and HUGEN professor.
WKSU-FM - No one knows what causes schizophrenia. It’s a devastating mental disorder that affects more than 3 million Americans. And while most people with schizophrenia can be treated, many don’t respond to medications. New research may find ways to help them. HUGEN’s VISHWAJIT NIMGAONKAR heads a team of researchers that’s looking at the genetic underpinnings of schizophrenia.
GENOME - "The project [tries to] present that there's a blending of genetics and environmental factors responsible for most anything we care about," HUGEN'S LISA PARKER says of the fact that the project aims to see a broader picture of how genes and environment can interact.
ALZFORUM - The latest function of the ALS-related protein FUS, is gene silencing mediated by micro RNAs. HUGEN’s UDAI PANDEY finds the study interesting because it reveals how mutations in FUS could have even more widespread consequences than previously thought. He added that the authors’ finding that a C. elegans homolog of FUS facilitates miRNA silencing indicates the pathway is highly conserved.
ASPPH FRIDAY LETTER - DNA determines what we look like, including our facial features. But first, researchers need to figure out which genes in our DNA are responsible for specific characteristics of our face. HUGEN’s SETH WEINBERG says, “In the past, scientists selected specific features, including the distance between the eyes or the width of the mouth. They would then look for a connection between this feature and many genes.” HUGEN's JOHN SH...
Honoring an individual who has a clearly articulated and enacted vision for advancing the scientific and business prowess of Pennsylvania, HUGEN's DIETRICH STEPHAN was honored with the 2017 award.
GEN NEWS – Scientists say they have identified fifteen genes that determine our facial features. HUGEN’s SETH WEINBERG describes the process before he and his team took on a new approach. “We're basically looking for needles in a haystack… This [approach] has already led to the identification of a number of genes but, of course, the results are limited because only a small set of features are selected and tested."
The Department of HUGEN is pleased to announce the promotion of QUASAR PADIATH to associate professor with tenure. His primary research interest is molecular mechanisms of neurological disorders, especially myelin formation and maintenance, using data on humans and mouse and fruit fly models.
MEDICAL X-PRESS - "At least 18 percent of individuals with pancreatic cancer and a personal history of other HBOC- or LS-related cancers carry mutations in a pancreatic cancer susceptibility gene based on our data, suggesting that criteria for genetic testing in individuals with pancreatic cancer should include consideration of previous cancer history," concludes HUGEN's BETH DUDLEY and colleagues.
HEALTH NEWS DIGEST - The current movement in breast cancer research is matching DNA with targeted therapies and HUGEN's ADRIAN LEE is at the forefront. "We know now that no two cancers are alike...the concept is, with our ability to more comprehensively understand the genetic basis of the disease, we can more precisely understand the disease, and then treat the disease and/or predict risk."
STREET INSIDER - Human genetic’s JERRY VOCKLEY, principal investigator on the program, noted, “I am very excited about our Phase 2 and other clinical results showing the near elimination of hypoglycemia and reduction in cardiomyopathy, addressing two of the major life-threatening symptoms in these disorders. A reduction in the frequency of rhabdomyolysis episodes will also greatly improve the lives of our patients. I look forward to continue work...